Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. GOCO
  6. >
  7. Earnings
stocks logo

GOCO Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of Gohealth Inc(GOCO) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Gohealth Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-11-13Pre-Market-2.06-0.19+90.78102.35M34.19M-66.60-24.27-31.98
FY2025Q22025-08-07Pre-Market-2.60-1.23+52.69110.30M94.05M-14.73-9.19-7.61
FY2025Q12025-05-13Pre-Market-0.26-0.47-80.77221.61M220.97M-0.29-0.25-12.30
FY2024Q42025-02-27Pre-Market1.162.41+107.76326.56M389.13M+19.16-14.45-13.63
FY2024Q22024-08-08Pre-Market-2.47--141.79M105.87M-25.33-20.78-30.13
FY2024Q12024-05-09--0.84-0.89-5.95178.80M185.60M+3.80-3.78-9.60
FY2023Q42024-03-14-2.730.60-78.02363.88M276.70M-23.96-13.17-22.21
FY2023Q32023-11-09--2.90-2.61+10.00138.25M132.04M-4.49-0.84+12.06
FY2023Q22023-08-10--2.66-1.77+33.46115.62M142.78M+23.49+4.19+7.82
-2023-05-08--1.74-1.12+35.63---+32.24+44.76
Intellectia AI SwingMax
Intellectia AI SwingMax

GOCO Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Gohealth Inc reported performance for FY2025Q3, announced on 2025-11-13. The company achieved an EPS of -0.19, compared to analyst estimates of -2.06 by 90.78% . Revenue for the quarter reached 34.19M compared to expectations of 102.35M by -66.60% .
The stock price reacted with a -24.27% one-day change and a -31.98% five-day change following the earnings release. These movements reflect market reaction in Gohealth Inc growth trajectory and strategic initiatives.

GOCO Earnings Forecast

Looking ahead, Gohealth Inc(GOCO) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 89.91M and an EPS of -2.18.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -32.29%, while EPS estimates have been Revise Upward by 1.16%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 12.39% . These revisions correlate with a -38.88% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Gohealth Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between GOCO's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward
down Image
-32.29%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.16%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
up Image
+12.39%
In Past 3 Month
Stock Price
Go Down
down Image
-38.88%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:539.76M
--
EPS Estimate-Annual FY 2025:-20.65
—
Stock Price2.94
Financial AI Agent
Financial AI Agent

GOCO Revenue and EPS Performance: A Historical Perspective

Gohealth Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-13,Pre-Market):
EPS: -0.19 (Actual) vs.-2.06 (Estimate) (90.78%)
Revenue: 34.19M (Actual) vs. 102.35M (Estimate) (-66.60%)
Price Reaction: -24.27%(1-Day), -31.98%(5-Day)
FY2025Q2 (2025-08-07,Pre-Market):
EPS: -1.23 (Actual) vs.-2.60 (Estimate) (52.69%)
Revenue: 94.05M (Actual) vs. 110.30M (Estimate) (-14.73%)
Price Reaction: -9.19%(1-Day), -7.61%(5-Day)
FY2025Q1 (2025-05-13,Pre-Market):
EPS: -0.47 (Actual) vs.-0.26 (Estimate) (-80.77%)
Revenue: 220.97M (Actual) vs. 221.61M (Estimate) (-0.29%)
Price Reaction: -0.25%(1-Day), -12.30%(5-Day)
Earnings Reaction
The chart below shows how GOCO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, GOCO sees a +16.13% change in stock price 10 days leading up to the earnings, and a -0.10% change 10 days following the report. On the earnings day itself, the stock moves by -5.03%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -2.69% on the day following the earnings release and then changed by 15.16% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
AI Stock Picker
AI Stock Picker

Transcript Summary

Gohealth Inc (GOCO) Q3 2025 Earnings Call Summary
Neutral
2025-11-13
The earnings call reflects a mixed sentiment. Positive aspects include strategic mergers, acquisitions, and a focus on technology and product diversification. However, concerns arise from the decision to pull back on new Medicare Advantage enrollments and management's lack of clarity on cash burn and sales ramp-up timelines. The Q&A section highlights a cautious approach towards growth and retention, aligning with broader industry trends. These factors balance each other out, resulting in a neutral overall sentiment.
Gohealth Inc (GOCO) Q2 2025 Earnings Call Summary
Neutral
2025-08-08
The earnings call reveals a mixed picture: positive developments like GoHealth Protect's launch and strategic M&A plans are offset by financial concerns such as intangible asset impairment and share dilution. The Q&A session highlights management's focus on strategic growth and financial flexibility, yet it also exposes uncertainties in revenue and cost structures. Given these factors, the sentiment is neutral, as positive aspects are balanced by financial challenges and market uncertainties.
Gohealth Inc (GOCO) Q1 2025 Earnings Call Summary
Negative
2025-05-14
Despite strong revenue growth and improved EBITDA, the negative cash flow, legal issues, and lack of clear guidance on future revenue trends overshadow positives. The DOJ lawsuit and potential AEP disruptions raise significant concerns. The absence of a share repurchase plan and unclear management responses further contribute to a negative sentiment. Given these factors, the stock price is likely to experience a negative reaction in the near term.
Gohealth Inc (GOCO) Q1 2025 Earnings Call Summary
Neutral
2025-05-13
The earnings call presents mixed signals: strong revenue growth, improved EBITDA, and reduced customer acquisition costs are positive. However, the negative cash flow, legal risks from the DOJ lawsuit, and lack of clear guidance are concerning. The market dynamics and operational efficiency are favorable, but uncertainties around the AEP and DOJ intervention pose risks. The Q&A highlights management's cautious outlook and lack of specific guidance, which tempers optimism. Overall, the sentiment is neutral given the balance of positive financials and significant uncertainties.
Gohealth Inc (GOCO) Q4 2024 Earnings Call Summary
Positive
2025-02-27
The earnings call presented strong financial performance with significant revenue and EBITDA growth, improved operational efficiency, and reduced customer acquisition costs. Despite negative cash flow, the refinancing of the term loan facility provides financial stability. The Q&A highlighted effective strategies and market positioning, with management addressing potential risks and opportunities. The overall sentiment is positive due to strong earnings, optimistic guidance, and strategic initiatives, indicating a likely positive stock price movement.
GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Summary
Neutral
2024-11-09
The earnings call presents a mixed picture. The acquisition of e-TeleQuote and refinancing of the term loan are positive developments. However, the decline in net revenues and adjusted EBITDA, along with the significant impact of a cyber-attack, are concerning. The Q&A section reveals cautious optimism but lacks specific guidance, especially regarding debt targets. The anticipated decline in cash flow from operations also tempers enthusiasm. Overall, the sentiment is balanced by positive strategic moves and operational challenges, leading to a neutral stock price prediction.
GoHealth, Inc. (GOCO) Q2 2024 Earnings Call Summary
Negative
2024-08-08
The earnings call summary indicates negative financial performance with declining revenues, negative EBITDA, and cash flow issues. The Q&A reveals management's vague responses on refinancing and capital structure, raising concerns. Competitive pressures are somewhat mitigated by competitor exits, but supply chain challenges and economic factors like premium increases present risks. The absence of a share buyback program further dampens sentiment. Overall, despite some positive aspects like improved agent efficiency, the negative financial metrics and lack of clear guidance suggest a negative stock price movement.

People Also Watch

FAQ

arrow icon

What were the key highlights of GOCO’s latest earnings report for FY2025Q3?

GOCO reported its FY2025Q3 earnings on 2025-11-13, showcasing a revenue of 34.19M against an estimate of 102.35M, resulting in a -66.6% surprise. The EPS was -0.19, surpassing the expected -2.06 by 90.78% . The stock experienced a -24.27% price change on the earnings day and a -31.98% change over the next five days, reflecting market reactions to the results.
arrow icon

How did GOCO’s stock price react after the FY2025Q3 earnings release?

Following GOCO’s FY2025Q3 earnings announcement on 2025-11-13, the stock price moved by -24.27% on the day of the release. Over the subsequent five days, it saw a -31.98% change. Historically, GOCO’s stock price tends to shift by an average of +16.13% in the 10 days leading up to earnings and -0.10% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for GOCO for 2025/Q4?

For 2025/Q4, analysts estimate GOCO’s annual revenue to reach 89.91M, while the EPS is projected at -2.18. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -32.29% and EPS estimates Revise Upward by 12.39% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does GOCO’s stock price correlate with earnings forecast revisions?

The correlation between GOCO’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -32.29%, while EPS estimates moved Revise Upward by 12.39% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from GOCO’s next earnings report?

Based on historical trends, GOCO’s stock price typically moves by +16.13% in the 10 days before its earnings and -0.10% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -2.18 and revenue of 89.91M.
arrow icon

What is the sentiment in Gohealth Inc (GOCO) Q3 2025 Earnings Call Summary?

The earnings call reflects a mixed sentiment. Positive aspects include strategic mergers, acquisitions, and a focus on technology and product diversification. However, concerns arise from the decision to pull back on new Medicare Advantage enrollments and management's lack of clarity on cash burn and sales ramp-up timelines. The Q&A section highlights a cautious approach towards growth and retention, aligning with broader industry trends. These factors balance each other out, resulting in a neutral overall sentiment.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free